Popular Articles
Teeth Whitening Products

Targacept's TC-5214 Achieves All Primary And Secondary Outcome Measures In Phase 2b Trial As Augmentation Treatment For Major Depressive Disorder
Targacept, Inc. (NASDAQ: TRGT) today announced positive top-line results from a double blind, placebo controlled, flexible dose Phase 2b clinical trial of TC-5214 as an augmentation (add-on) treatment for major depressive disorder, or MDD, in subjects who did not respond adequately to first-line treatment with citalopram alone. The result on the primary outcome measure for the trial, mean change between treatment (TC-5214 + citalopram) and placebo (placebo + citalopram) from baseline on the Hamilton Rating Scale for Depression-17, or HAM-D, was highly statistically significant in favor of TC-5214 (p Next Steps
generic viagra online
Cancer Research UK Aims For Positive End To 'Bad Day'
THIS month, Cancer Research UK is set to unveil a brand new national television ad campaign to raise awareness and increase donations for vital research into cancer.
News of the day
Molecular Machinery Related To Stem Cell Fate Revealed By Xie Lab
The Stowers Institute"s Xie Lab has revealed how the BAM protein affects germline stem cell differentiation and how it is involved in regulating the quality of stem cells through intercellular competition. The work was published by PNAS Early Edition.
Health Insurance

NSAIDs Can Reduce Common Cold Symptoms

The common cold is the most pervasive recurring illness on earth. For years, people have turned to nonsteroidal anti-inflammatory drugs, or NSAIDs, to relieve pain, fever and other symptoms related to the miserable feelings brought on by the common cold. NSAIDs include ibuprofen, which is available in brands such as Motrin and Advil, and naproxen, which is marketed as Aleve. A new Cochrane review of nine studies has found that NSAIDs are effective in reducing many cold symptoms. It is important to note, however, that NSAIDs can relieve symptoms of the common cold not prevent or treat the illness. "The review found that NSAIDs improved most analgesia-related symptoms such as headache, ear pain, and muscle and joint pain," said lead author Soo Young Kim, M.D., a professor at Hallym University Medical College in Seoul, South Korea. "We also found that NSAIDs significantly improved sneezing associated with the common cold." Kim and his colleagues looked at whether NSAIDs were more effective than placebos for reducing common cold symptoms. The studies included 1,064 children and adults suffering from a cold. The participants did not have an acute illness or a chronic health condition. In six studies, 891 participants had acquired the cold before the study began, while 178 participants in three other studies were infected deliberately. Treatment duration ranged from a single dose to two doses a day for seven days. The review appears in the latest issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews like this one draw evidence-based conclusions abut medical practice after considering both the content and quality of existing medical trials on a topic. The investigators found that NSAIDs are beneficial in treating many cold symptoms, but not all cold symptoms. "That"s due to the fact that many symptoms of the common cold are caused by inflammation due to viruses that do not appear in a single pathway," Kim said. For example, reviewers found no clear evidence that NSAIDs are effective in improving respiratory symptoms such as cough and nasal discharge. "If a person has a cough caused by a cold, the American College of Chest Physicians has recommended the administration of naproxen," Kim said. "Further research is needed to evaluate the benefits of NSAIDs for relieving respiratory symptoms." Norman Edelman M.D., chief medical officer of the American Lung Association, agrees with the review findings. "Nonsteroidal anti-inflammatory drugs provide relief for many symptoms of the common cold," he said. "Even though they alleviate cold symptoms for many patients, it is unlikely that consumers expect NSAIDs to provide relief from all symptoms of the common cold. The review confirms the behavior of many consumers who are looking for a reduction of cold symptoms." Edelman noted that while the review investigated common cold symptoms and not the flu, it did not distinguish the difference between cold and influenza symptoms. "Even though fever is associated with the flu, not every person who is taking an NSAID recognizes that," he said. "If they are taking an NSAID to treat common cold symptoms, they may think their fever is due to a cold, but in realty, it may be influenza." The Cochrane Collaboration is an international nonprofit, independent organization that produces and disseminates systematic reviews of health care interventions and promotes the search for evidence in the form of clinical trials and other studies of interventions. Kim SY, et al. Non-steroidal anti-inflammatory drugs for the common cold. Cochrane Database of Systematic Reviews Issue 3, 2009. Health Behavior News Service


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):